Their expression may result in the overactivation of glial cells, dysregulation of enzymes like BACE1 and ADAM10, and impaired clearance of amyloid-β, hence worsening the pathological hallmarks of AD [76,77]. This evidence concerns the gene BACE1 and Alzheimer disease.